VBI Vaccines Statistics
Share Statistics
VBI Vaccines has 28.68M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 28.68M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 269,628 |
| FTD / Avg. Volume | 3.21% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -0.1 and the forward
PE ratio is null.
VBI Vaccines's PEG ratio is
0.
| PE Ratio | -0.1 |
| Forward PE | n/a |
| PS Ratio | 1.05 |
| Forward PS | n/a |
| PB Ratio | 1.22 |
| P/FCF Ratio | -0.15 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
VBI Vaccines has an Enterprise Value (EV) of 38.5M.
| EV / Sales | 4.43 |
| EV / EBITDA | -0.72 |
| EV / EBIT | -0.63 |
| EV / FCF | -0.62 |
Financial Position
The company has a current ratio of 0.48,
with a Debt / Equity ratio of 7.05.
| Current Ratio | 0.48 |
| Quick Ratio | 0.37 |
| Debt / Equity | 7.05 |
| Debt / EBITDA | -0.99 |
| Debt / FCF | -0.86 |
| Interest Coverage | -6.86 |
Financial Efficiency
Return on Equity is -1233.37% and Return on Invested Capital is -93.11%.
| Return on Equity | -1233.37% |
| Return on Assets | -106.77% |
| Return on Invested Capital | -93.11% |
| Revenue Per Employee | $66,274.81 |
| Profits Per Employee | $-708,671.76 |
| Employee Count | 131 |
| Asset Turnover | 0.1 |
| Inventory Turnover | 1.71 |
Taxes
| Income Tax | 1.82M |
| Effective Tax Rate | -1.96% |
Stock Price Statistics
The stock price has increased by -88.14% in the
last 52 weeks. The beta is 2.17, so VBI Vaccines's
price volatility has been higher than the market average.
| Beta | 2.17 |
| 52-Week Price Change | -88.14% |
| 50-Day Moving Average | 0.35 |
| 200-Day Moving Average | 0.55 |
| Relative Strength Index (RSI) | 21.98 |
| Average Volume (20 Days) | 8,393,583 |
Income Statement
In the last 12 months, VBI Vaccines had revenue of 8.68M
and earned -92.84M
in profits. Earnings per share was -5.96.
| Revenue | 8.68M |
| Gross Profit | -5.82M |
| Operating Income | -55.31M |
| Net Income | -92.84M |
| EBITDA | -53.32M |
| EBIT | -84.77M |
| Earnings Per Share (EPS) | -5.96 |
Full Income StatementBalance Sheet
The company has 23.68M in cash and 53.04M in
debt, giving a net cash position of -29.36M.
| Cash & Cash Equivalents | 23.68M |
| Total Debt | 53.04M |
| Net Cash | -29.36M |
| Retained Earnings | -582.45M |
| Total Assets | 75.44M |
| Working Capital | -51.23M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -60.88M
and capital expenditures -867K, giving a free cash flow of -61.75M.
| Operating Cash Flow | -60.88M |
| Capital Expenditures | -867K |
| Free Cash Flow | -61.75M |
| FCF Per Share | -3.97 |
Full Cash Flow StatementMargins
Gross margin is -66.98%, with operating and profit margins of -637.08% and -1069.29%.
| Gross Margin | -66.98% |
| Operating Margin | -637.08% |
| Pretax Margin | -1069.29% |
| Profit Margin | -1069.29% |
| EBITDA Margin | -614.16% |
| EBIT Margin | -637.08% |
| FCF Margin | -711.24% |
